Circulation, 146, 657-672 Circulation : an official journal of the American Heart Association / ed.-in-chief Ephraim Donosco 146(9), 657-672 (2022). doi:10.1161/CIRCULATIONAHA.121.057807 Hagström, E, Steg, P G, Szarek, M, Bhatt, D L, Bittner, V A, Danchin, N, Diaz, R, Goodman, S G, Harrington, R A, Jukema, J W, Liberopoulos, E, Marx, N, McGinniss, J, Manvelian, G, Pordy, R, Scemama, M, White, H D, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Investigators & Bøttcher, M 2022, ' Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab ', Circulation, vol. 146, no. 9, pp. 657-672 . https://doi.org/10.1161/CIRCULATIONAHA.121.057807 Circulation, vol 146, iss 9 Circulation, 146, 9, pp. 657-672 Circulation, Philadelphia : Lippincott Williams & Wilkins, 2022, vol. 146, iss. 9, p. 657-672 Circulation, 146(9), 657-672. LIPPINCOTT WILLIAMS & WILKINS
Repositorio Universidad de Santander Universidad de Santander instacron:Universidad de Santander Circulation Circulation, 140(19), 1578-1589. LIPPINCOTT WILLIAMS & WILKINS Roe, M T, Li, Q H, Bhatt, D L, Bittner, V A, Diaz, R, Goodman, S G, Harrington, R A, Jukema, J W, Lopez-Jaramillo, P, Lopes, R D, Louie, M J, Moriarty, P M, Szarek, M, Vogel, R, White, H D, Zeiher, A M, Baccara-Dinet, M T, Steg, P G, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Gislason, G, Davidsen, F & Videbaek, L 2019, ' Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes ', Circulation, vol. 140, no. 19, pp. 1578-1589 . https://doi.org/10.1161/CIRCULATIONAHA.119.042551 Circulation, 140(19), 1578-1589. Lippincott Williams & Wilkins
Journal of the American College of Cardiology, 74(9), 1167-1176 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Journal of the American College of Cardiology
Journal of the American College of Cardiology, 73(4), 387-396. ELSEVIER SCIENCE INC Journal of the American College of Cardiology JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname
White, H D, Steg, P G, Szarek, M, Bhatt, D L, Bittner, V A, Diaz, R, Edelberg, J M, Erglis, A, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Lopes, R D, Mahaffey, K W, Moryusef, A, Pordy, R, Roe, M T, Sritara, P, Tricoci, P, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Davidsen, F & Videbaek, L 2019, ' Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial ', European Heart Journal, vol. 40, no. 33, pp. 2801-2809 . https://doi.org/10.1093/eurheartj/ehz299 European Heart Journal, 40(33), 2801-2809. OXFORD UNIV PRESS European Heart Journal Volume 40 Issue 33 European Heart Journal, 40(33), 2801-2809. Oxford University Press European heart journal EUROPEAN HEART JOURNAL r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname European heart journal 40(33), 2801-2809 (2019). doi:10.1093/eurheartj/ehz299 special issue: "Focus Issue on LIPIDS"